Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,796 | -25,258 | -18,592 | -18,163 | -19,931 |
| Depreciation Amortization | 2,583 | 2,098 | 1,329 | 418 | 2,078 |
| Accounts receivable | -876 | N/A | N/A | -1,247 | N/A |
| Other Working Capital | -7,489 | -8,813 | -3,355 | -8,774 | -7,829 |
| Other Operating Activity | 17,658 | 11,354 | 7,005 | 4,562 | 11,525 |
| Operating Cash Flow | $-45,920 | $-20,619 | $-13,613 | $-23,204 | $-14,157 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,351 | -1,337 | -1,180 | -317 | -569 |
| Purchase Of Investment | -118,662 | -26,482 | -9,734 | -6,238 | -194,927 |
| Sale Of Investment | 158,848 | 133,348 | 105,604 | 63,284 | 289,971 |
| Investing Cash Flow | $38,835 | $105,529 | $94,690 | $56,729 | $94,475 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,553 | 962 | 721 | 167 | 496 |
| Other Financing Activity | 249,745 | 0 | 0 | 0 | -1,375 |
| Financing Cash Flow | $252,298 | $962 | $721 | $167 | $-879 |
| Beginning Cash Position | 250,516 | 250,516 | 250,516 | 250,516 | 171,077 |
| End Cash Position | 495,729 | 336,388 | 332,314 | 284,208 | 250,516 |
| Net Cash Flow | $245,213 | $85,872 | $81,798 | $33,692 | $79,439 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,920 | -20,619 | -13,613 | -23,204 | -14,157 |
| Capital Expenditure | -1,366 | -1,352 | -1,180 | -317 | -569 |
| Free Cash Flow | -47,286 | -21,971 | -14,793 | -23,521 | -14,726 |